Little T agree, T/0 price is hard to predict,
I like to think of Neuren's valuation as pre FDA approval and post FDA approval.
A T/O valuation pre FDA approval will be vastly different to one after. I'm hoping we are still around to see the full potential of this company with milestone payments and double digit royalties. Valuation $15 to $20 after Trofs approval.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.62 |
Change
-0.160(0.90%) |
Mkt cap ! $2.211B | |||
| Open | High | Low | Value | Volume |
| $17.67 | $18.02 | $17.52 | $8.435M | 476.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32 | $17.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.63 | 1262 | 2 |
View Market Depth
| Last trade - 16.15pm 11/08/2025 (20 minute delay) ? |
| NEU (ASX) Chart |